Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
PHASE1
18 participants
INTERVENTIONAL
2006-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of RLX030 in Pregnant Women With Pre- Eclampsia
NCT01566630
Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia
NCT06157580
Losartan for Improved Vascular Endothelial Function After Preeclampsia
NCT04632589
Regulation of Placental Vascular Reactivity in Pregnancy-induced Hypertension
NCT00005208
Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)
NCT02221830
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
recombinant human relaxin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hospital admission for expectant management
Exclusion Criteria
* Vaginal bleeding
* Multifetal gestation
* Requirement for immediate delivery
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sam Teichman, MD
Role: STUDY_DIRECTOR
Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Central Baptist Hospital
Lexington, Kentucky, United States
University of Cincinnati
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RLX.PE.001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.